BioXcel Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
BioXcel Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2020 to Q4 2024.
  • BioXcel Therapeutics, Inc. Other Assets, Current for the quarter ending December 31, 2024 was $1.44M, a 30.7% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.44M -$638K -30.7% Dec 31, 2024 10-K 2025-03-28
Q3 2024 $1.4M -$773K -35.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.64M -$2.99M -64.6% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.86M -$3.15M -62.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.08M -$1.77M -45.9% Dec 31, 2023 10-K 2025-03-28
Q3 2023 $2.17M -$259K -10.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.64M +$2.94M +174% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $5.01M +$3.53M +239% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.84M +$2.89M +302% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $2.43M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.69M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.48M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $956K -$28K -2.85% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $984K Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.